Amgen (AMGN) Change in Inventory (2009 - 2026)

Amgen's Change in Inventory history runs 18 years deep, the most recent figure standing at -$18.0 million for Q1 2026.

• In Q1 2026, Change in Inventory rose 93.75% year-over-year to -$18.0 million; the TTM figure through Mar 2026 stood at -$616.0 million (up 69.41% YoY), while the FY2025 annual figure was -$886.0 million, up 65.01% from the prior year.
• Change in Inventory was -$18.0 million for Q1 2026 at Amgen, up from -$119.0 million in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $241.0 million in Q3 2022 to a low of -$806.0 million in Q1 2024.
• Historically, Change in Inventory has averaged -$187.4 million across 5 years, with a median of -$119.0 million in 2025.
• The sharpest annual moves came in 2022 and 2024: Change in Inventory surged 402.08% in 2022, then slumped 2306.67% in 2024.
• A 5-year view of Change in Inventory shows it stood at $91.0 million in 2022, then slumped by 729.67% to -$573.0 million in 2023, then soared by 43.63% to -$323.0 million in 2024, then jumped by 63.16% to -$119.0 million in 2025, then soared by 84.87% to -$18.0 million in 2026.
• The last three Change in Inventory figures came in at -$18.0 million (Q1 2026), -$119.0 million (Q4 2025), and -$240.0 million (Q3 2025), per Business Quant data.